课题基金 / 基金详情

Cell Interactions In Three Dimensional Tissue Culture

Cell Interactions In Three Dimensional Tissue Culture
三维组织培养中的细胞相互作用
批准号:
6541163
负责人:
Leonid B. Margolis
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Leonid B. Margolis的其他基金

相似基金

相关文献

中文摘要
翻译
HIV疾病的关键事件发生在淋巴组织中,在那里HIV杀死受感染的CD4+细胞以及许多未感染的细胞,扰乱调节正常免疫反应的复杂的细胞-细胞相互作用系统。该项目的总体目标是利用我们的体外感染的人扁桃体系统来确定艾滋病毒-1介导的免疫病理的潜在机制(S)。在体内,HIV-1单独或与CCR5辅受体结合使用CXCR4辅受体的能力往往与大量的CD4+T细胞丢失和疾病的快速发展有关。我们目前正在测试的工作假设是,决定CXCR4使用的HIV-1 env基因,单独或与CCR5一起使用,足以诱导T细胞耗尽和免疫抑制。此外,我们还研究了HIV辅助基因,特别是nef基因在病毒组织细胞病变中的作用。早些时候,我们发现,共受体的特异性决定了B亚型单嗜性HIV-1变异体的细胞致病性。今年,我们研究了(I)共受体特异性是否决定了B亚型以外的HIV-1亚型变异体的细胞致病性;(Ii)B亚型双嗜性R5X4 HIV-1变异体的细胞致病性是否取决于它们对特定辅受体的优先使用;以及(Iii)HIV辅助基因nef在HIV发病中的作用是否与细胞表面受体的调节有关。为了研究非B亚型的R5和X4 HIV-1变异体的体外细胞致病性,我们使用了A、E和C亚型的原代分离株以及B亚型的原型变异体。我们没有观察到病毒复制的最大水平与辅助受体的使用或病毒亚型之间的关系。然而,我们确实观察到在所有被测试的亚型中,病毒辅助受体的使用与CD4+T淋巴细胞耗竭之间存在很强的相关性。所有R5 HIV-1感染都会导致CD4+T细胞轻度耗尽,而所有X4 HIV-1感染都会导致CD4+T细胞严重耗尽,无论其亚型如何。因此,非B型HIV-1亚型与HIV-1亚型B亚型相似,因为共同受体的特异性决定了体外感染的人淋巴组织中的细胞病变。为了了解R5X4病毒的不同细胞病变是否也与它们优先使用特定的辅助受体有关,我们用三个R5X4 HIV-1变异体:89.6、89-v345.FL和89-v345.SF感染CCR5 delta32组织,后两个变异体除gp120的V3-V5区域外,其余两个与89.6同源。变异体89.6会严重耗尽组织中的CD4+T细胞,而89-v345.SF只会轻微耗尽组织。变异体89-v345.FL为中间耗竭基因。在CCR5 delta32和正常淋巴组织中,89.6和89-v345.FL以相似的动力学方式复制。相反,-v345.SF不能在缺乏CCR5的淋巴组织中复制。与这些结果一致,89.6的复制完全被CXCR4配体AMD3100抑制,但对CCR5配体RANTES不敏感,而89-v345.SF的复制几乎完全被RANTES抑制,但不被AMD3100抑制。AMD3100和RANTES均可降低89-v345.FL的复制。在两个被研究的原代分离株中,其中一个不被RANTES抑制,但几乎完全被AMD3100阻断,这两个原代分离株在转基因细胞系中具有双向性。因此,在淋巴组织中,一些R5X4分离株似乎专门利用CXCR4,而另一些分离株则专门利用CCR5。优先使用CXCR4的HIV变种高度细胞病变,而优先使用CCR5的HIV变种轻度消耗CD4+T细胞。因此,优先使用辅受体决定了R5X4变异体的细胞致病性。细胞表面受体可能介导辅助基因nef在HIV感染中的作用。分别用患者连续分离株中携带nef等位基因的NL4-3克隆和携带重组基因的克隆感染组织。在较晚的时间点分离的含有nef等位基因的HIV-1变异株的复制水平比最初在早期分离的含有nef等位基因的HIV-1变异株高两到三倍。较高的复制水平与有效耗尽CD4+T细胞相关。在体外感染的组织中,CD4下调中的Nef活性与病毒复制的效率之间存在显著的相关性,这表明Nef介导的CD4下调、病毒复制和疾病进展之间存在联系。综上所述,HIV-1变异体的共受体偏好是B亚型和非B亚型单嗜性病毒以及双嗜性病毒细胞致病性的充分决定因素;细胞表面受体的下调可能介导淋巴组织中HIV-1感染的NEF效应。
英文摘要
Critical events in HIV disease occur in lymphoid tissue where HIV kills infected CD4+ cells as well as many non-infected cells, disrupting a complex system of cell-cell interactions that mediate normal immune response. The general aim of the project is to determine the underlying mechanism(s) of HIV-1-mediated immunopathogenesis using our system of ex vivo-infected human tonsils. In vivo the ability of HIV-1 to use CXCR4 coreceptor exclusively or in addition to CCR5 coreceptor is often associated with massive loss of CD4+ T cells and rapid disease progression. The working hypothesis we are currently testing is that the HIV-1 env gene that determines the usage of CXCR4, exclusively or in addition to CCR5, is sufficient to induce T cell depletion and immunosuppression. Also, we investigate the contribution of HIV accessory genes, in particular that of nef gene to viral tissue cytopathicity. Earlier we showed that coreceptor specificity determines cytopathicity of mono-tropic HIV-1 variants of B subtype. This year we investigated (i) whether co-receptor specificity determinines cytopathicity of HIV-1 variants of subtypes other than B; (ii) whether the cytopathicity of dual-tropic R5X4 HIV-1 variants of B subtype is determined by their preferential usage of a particular co-receptor, and (iii) whether the contribution of an HIV accessory gene nef to HIV pathogenesis is associated with modulation of cell surface receptors. To investigate the ex vivo cytopathicity of R5 and X4 HIV-1 variants of non-B subtypes, we used primary isolates of subtypes A, E, and C and prototypic subtype B variants. We observed no relationship between the maximal level of viral replication and either coreceptor usage or viral subtype. However, we did observe a strong correlation between viral coreceptor usage and CD4+ T lymphocyte depletion across all subtypes tested. All R5 HIV-1 infections resulted in mild depletion of CD4+ T cells, whereas all X4 HIV-1 infections caused severe depletion of CD4+ T cells irrespective of their subtype. Thus, non-B HIV-1 subtypes are similar to HIV-1 subtype B in that coreceptor specificity determines cytopathicity in human lymphoid tissue infected ex vivo. To find out whether differential cytopathicity of R5X4 viruses is also related to their preferential use of a particular coreceptor, we infected CCR5 delta32 tissue with three R5X4 HIV-1 variants: 89.6, 89-v345.FL, and 89-v345.SF; the latter two are isogenic to 89.6 except for the V3-V5 region of gp120. Variant 89.6 severely depletes tissue of CD4+ T cells, whereas 89-v345.SF depletes only mildly. Variant 89-v345.FL was an intermediate depletor. Both in CCR5 delta 32 and in normal lymphoid tissue, 89.6 and 89-v345.FL replicated with similar kinetics. In contrast, 89-v345.SF did not replicate in lymphoid tissue lacking CCR5. In agreement with these results, replication of 89.6 was completely inhibited by an CXCR4 ligand AMD3100 but was insensitive to a CCR5 ligand RANTES, whereas 89-v345.SF replication was almost completely inhibited by RANTES but not by AMD3100. Replication of 89-v345.FL was reduced both by AMD3100 and by RANTES. Among two studied primary isolates, which were dual-tropic in transfected cell lines, one was not inhibited by RANTES but was almost completely blocked by AMD3100. Thus, in lymphoid tissues some R5X4 isolates appear to utilize CXCR4 exclusively, whereas others use CCR5 exclusively. R5X4 HIV variants that use CXCR4 preferentially are highly cytopathic, whereas those preferentially using CCR5 deplete CD4+ T cells mildly. Hence, preferential coreceptor usage determines cytopathicity of R5X4 variants. Cell surface receptors may mediate the effects of an accessory gene nef on HIV infection. Tissues were infected with NL4-3 clones bearing nef alleles from sequential patient's isolates, as well as with clones bearing recombinant alleles. The HIV-1 variants containing the nef alleles isolated at later time points showed two- to-three fold higher levels of replication than those containing the nef alleles initially isolated at the early time point. Higher levels of replication correlated with efficient depletion of CD4+ T cells. There was a significant correlation between Nef activity in CD4 down-regulation and the efficiency of virus replication in ex vivo-infected tissue, suggesting a link between Nef-mediated CD4 downregulation, viral replication, and disease progression. In summary, coreceptor preference of HIV-1 variants is a sufficient determinant of viral cytopathicity for monotropic viruses of B and non-B subtypes as well as for dual-tropic viruses; and down-modulation of cell surface receptors may mediate nef-effects on HIV-1 infection in lymphoid tissue.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MORPHOLOGICAL DYNAMICS OF CELL DIFFERENTIATION
  • 批准号:
    2291917
  • 项目类别:
  • 资助金额:
    $6.49万
  • 财政年份:
    1995
  • 负责人:
    Leonid B. Margolis
  • 依托单位:
MORPHOLOGICAL DYNAMICS OF CELL DIFFERENTIATION
  • 批准号:
    2291919
  • 项目类别:
  • 资助金额:
    $0.25万
  • 财政年份:
    1995
  • 负责人:
    Leonid B. Margolis
  • 依托单位:
Cell Interactions in Three Dimensional Tissue Culture
Cell Interactions in Three Dimensional Tissue Culture
海外基金